Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Proreo Pharma International

2002 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a specialty pharmaceutical company in Switzerland. The company provides a drug for the treatment of life-threatening bleeding disorder associated with liver diseases such as cirrhosis and hepatitis.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Weierweg 7
  • 4410 Liestal
  • Switzerland

+41 061 000 00 00

Proreo Pharma International Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Proreo Pharma International‘s full profile, request access.

Request full access to PitchBook

Proreo Pharma International Executive Team (2)

Name Title Board
Seat
Contact
Info
Rudolf Syz Co-Founder & Managing Director
Günter Graubach Chairman & Founder

Proreo Pharma International Board Members (1)

Name Representing Role Since Contact
Info
0ü0000 00000000 Proreo Pharma International Chairman & Founder 000 0000